Creatine Monohydrate
Inquiry
| Post Date: | Feb 25,2022 |
| Expiry Date: | Feb 25,2023 |
| Detailed Description: |
Cas No. :6020-87-7
Creatine Monohydrate is the best bodybuilding supplement to boost strength and muscle size, as well as aiding in explosive training and performance. Creatine Monohydrate has been widely used by bodybuilders, performance athletes, and those looking to quickly increase strength and add muscle to their physique.
For best results, creatine monohydrate should be mixed with a juice to spike insulin levels and shuttle more creatine monohydrate into muscle cells. Using creatine monohydrate experienced more explosive power and upsurge in muscular contraction; leading to drastic strength gains and recovery. Athletes, bodybuilders, or casual fitness enthusiasts should consume ample amounts of water when using creatine monohydrate. Creatine increases ATP production which fuels the mitochondria of the cells. ATP is like the spark plug that drives cellular and physical activity, and creatine monohydrate greatly aids in up-cycling your energy and stamina. |
| CAS Registry Number: | 6020-87-7 |
| Synonyms: | ;Amidinosarcosine Monohydrate;N-carbamimidoyl-N-methylglycine hydrate (1:1);[(diaminomethylidene)(methyl)ammonio]acetate; |
| Molecular Formula: | C4H9N3O2 |
| Molecular Weight: | 131.1332 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xi:Irritant; |
| Risk Codes: | R36/37/38:; |
| Safety Description: | S26:; |
| Company: | Rishon Biochem Co., Ltd [ China ] |
| Contact: | Lei Cheng |
| Tel: | 00868386661786 |
| Fax: | 00868382566283 |
| Email: | info@rishonbiochem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
